(Q42543071)

2 November 2017

title

Synthesis of N-alkyl substituted indolocarbazoles as potent inhibitors of human cytomegalovirus replication (English)

1 reference

2 November 2017

0 references

1 reference

ChEBI release 2020-05-28

Slater MJ

1

1 reference

2 November 2017

Baxter R

2

1 reference

2 November 2017

Bonser RW

3

1 reference

2 November 2017

Cockerill S

4

1 reference

2 November 2017

Gohil K

5

1 reference

2 November 2017

Parry N

6

1 reference

2 November 2017

Robinson E

7

1 reference

2 November 2017

Randall R

8

1 reference

2 November 2017

Yeates C

9

1 reference

2 November 2017

Snowden W

10

1 reference

2 November 2017

Walters A

11

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

2 November 2017

published in

1 reference

2 November 2017

volume

11

1 reference

2 November 2017

issue

15

1 reference

2 November 2017

page(s)

1993-1995

1 reference

Risk factors for cytomegalovirus infection after human marrow transplantation

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Cytomegalovirus Infections Following Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Summary of the II International Symposium on Cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Recent advances in the therapy and prevention of CMV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Antisense approach for the treatment of cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Total Synthesis of (+)- and (-)-K252a

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Synthesis and anti-herpes virus activity of 2'-deoxy-4'-thiopyrimidine nucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

Evidence that a second stereochemical centre in diacylglycerols defines interaction at the recognition site on protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900352-3

7 January 2021

10.1016/S0960-894X(01)00352-3

Identifiers

DOI

1 reference

2 November 2017

1 reference